Age, Biography and Wiki

Charis Eng was born on 1962 in Singapore, is a Singapore-born physician and geneticist. Discover Charis Eng's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 58 years old?

Popular As N/A
Occupation Geneticist
Age 59 years old
Zodiac Sign N/A
Birthplace Singapore
Nationality US

We recommend you to check the complete list of Famous People born on . She is a member of famous with the age 59 years old group.

Charis Eng Height, Weight & Measurements

At 59 years old, Charis Eng height not available right now. We will update Charis Eng's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Charis Eng Net Worth

Her net worth has been growing significantly in 2020-2021. So, how much is Charis Eng worth at the age of 59 years old? Charis Eng’s income source is mostly from being a successful . She is from US. We have estimated Charis Eng's net worth, money, salary, income, and assets.

Net Worth in 2021 $1 Million - $5 Million
Salary in 2020 Under Review
Net Worth in 2019 Pending
Salary in 2019 Under Review
House Not Available
Cars Not Available
Source of Income

Charis Eng Social Network

Twitter Charis Eng Twitter
Wikipedia Charis Eng Wikipedia



Eng additionally has sat on many boards including a 3-year term on the Board of Directors of the American Society of Human Genetics, a 2-year term as Chair of the Clinical Science Committee of the Personalised Medicine Coalition and a 5-year term on the Board of Scientific Directors of the National Human Genome Research Institute. Eng was appointed to the US Department of Health and Human Services’ Secretary’s Advisory Committee on Genetics, Health and Society (2009–11).  She also was co-chair of their Task Force to examine whole genome sequencing for clinical application, and serves on the Expert Panel of the WHO Grand Challenges Project on Public Health Genomics in Developing Countries.


Eng was recruited to the Cleveland Clinic in 2005, and was founding director of the Cleveland Clinic's Genomic Medicine Institute and the Center for Personalized Genetic Healthcare, and professor and vice chair of the Department of Genetics at Case Western Reserve University School of Medicine.

Eng has received numerous awards and honours including election to the American Society of Clinical Investigation, the Association of American Physicians, a Fellow of AAAS, and the Doris Duke Distinguished Clinical Scientist Award. Eng received the 2005 ATA Van Meter Award, the 2006 Ernst Oppenheimer Award of The Endocrine Society and the 2006 American Cancer Society John Peter Minton, MD, PhD Hero of Hope Research Medal of Honour, 2014 James Ewing Lecturer of the Society of Surgical Oncology and the 2014 AACR-WICR Charlotte Friend Memorial Lecturer. In 2018 Eng was awarded a Medal of Honour for Clinical Research by the American Cancer Society "for her leadership in personalized care, translating genomic and cellular analysis to clinical practice." Eng has also received the Stefanie Spielman Breast Cancer Research Award.


Eng was born in Singapore 1962 and grew up in Bristol, England. She started studying at the University of Chicago aged 16. She earned her Ph.D. in Developmental Biology in 1986 and her M.D. in 1988, both from the Pritzker School of Medicine, University of Chicago. Then specialising in internal medicine at Beth Israel Hospital, Boston and trained in medical oncology at Harvard’s Dana-Farber Cancer Institute. Eng then trained in clinical cancer genetics at the University of Cambridge and the Royal Marsden NHS Trust, UK, and in laboratory-based human cancer genetics by Prof Sir Bruce Ponder. Eng returned to the Farber as Assistant Professor of Medicine at the end of 1995, and in January, 1999 was recruited by The Ohio State University as Associate Professor of Medicine and Director of the Clinical Cancer Genetics Program. In 2001, she was bestowed the Davis Professorship and appointed Co-Director of the Division of Human Genetics in the Department of Internal Medicine. In 2002, she was promoted to Professor and Division Director, and became the Klotz Endowed Chair